Memphis R&D Assets
Orthopaedic Center of Excellence
The rapid emergence of Memphis as the United States center of orthopaedic research and development has resulted from years of steady infrastructure growth in support of the bioscience, biomedical, and healthcare industries. Creating the necessary facilities, environment, and resources has led to a critical mass where the confluence of time, place, and energy will generate sustained and ongoing growth far into the future.
Today, Memphis is a worldwide leader in orthopaedic and spinal implants and the second-largest center for orthopaedic device manufacturing, capturing an estimated 20% ($6.5 billion) of global orthopaedic revenues.
Memphis Medical Center
UT-Baptist Research Park is located in the heart of the Memphis Medical Center, a vital, functioning medical district that serves as the center for medical and bioscience research, development, and treatment for the Mid-South. Life-saving research is taking place at the University of Tennessee and at area institutions, including St. Jude Children's Research Hospital, Methodist University Hospital, and the Dept. of Veterans Affairs Medical Center. Numerous other medical and medical support facilities and businesses thrive in the center.
A few years ago, major stakeholders in the Memphis Medical Center engaged architects Looney Ricks Kiss to update a master plan for this key part of the City of Memphis, with the UT - Baptist Research Park playing a critical role.
The Memphis Medical Center seeks to create a sense of place by addressing the common concerns — zoning, security, streets and sidewalks and other important infrastructures, economic development factors, transportation, housing, parks, even signage.
The overall mission: to pursue the priorities outlined in the master plan so that the Memphis Medical Center can become a place where education, innovative research, development and clinical care matters each day, is attractive to both business and new talent from across the country, and is a safe and nurturing place for health and healthy living.
Regional Biocontainment Laboratory
In 2003, UTHSC was awarded nearly $18 million in federal funding from the National Institutes of Allergy and Infectious Disease (NIAID) to build a laboratory on the UT-Baptist Research Park site for biomedical and biodefense research and research training. Completed in 2009, the UTHSC RBL is now one of 13 NIAID funded Regional Biocontainment Laboratories in the country.
The primary purpose of the research conducted at the RBL is to develop new drugs, vaccines, and diagnostics to protect the general population from infectious diseases and bioterrorism. The UTHSC RBL will be limited to research requiring Biosafety Level 3 (BSL-3) containment as defined by the Centers for Disease Control to safely and effectively study contagious materials. Scientists at the UT RBL investigate multi-drug resistant tuberculosis, tularemia, streptococci, cholera and Chlamydia infections. Other pathogens will be added as the facility and faculty expand. UTHSC was selected as a site to develop vaccines for infectious diseases that pose a serious health threat to humanity.
The lab was the first new facility to be built at the UT-Baptist Research Park and the new facility was completed in June 2009. The laboratory is approximately 31,000 square feet and was built at a cost of $25 million.
The facility provides a safe environment in which scientists and researchers can work on infectious disease agents:.
- Used for bio and microbiological research on regional and national level.
- Consists of a suite of highly secure biosafety laboratories, as well as space for training, security, and support.
- BSL-2 and BSL-3 space.
- Local research partners include Memphis Bioworks Foundation, Dept. of Veterans Affairs Medical Center, Memphis Medical Center, St. Jude Children's Research Hospital, the Shelby County Health Department, and Le Bonheur Children's Medical Center. The Jackson Laboratory of Bar Harbor, Maine, will also partner with the university on select projects.
For more information, visit: www.uthsc.edu/research/RBL
University of Tennessee Health Science Center
Adjacent to UT-Baptist Research Park, the UT Health Science Center is home to the state’s largest medical school, a pharmacy school with active drug development research initiatives, and many strong existing research programs. With nearly $100 million awarded annually in external funding for research and sponsored programs, UTHSC research centers include:
Centers of Excellence:
- Center for Pediatric Pharmakokinetics and Therapeutics
- Center of Excellence for Neuroscience
- Connective Tissues Diseases, Center of Excellence
- Molecular Resource Center of Excellence
- Rheumatic Disease Research Core Center
Research Programs and Institutes:
- Center for Cancer Research
- Center for Integrative and Translational Genomics
- Clinical and Translational Science Institute
- General Clinical Research Center
- Hamilton Eye Institute
- Proteome and Transcription Database
- Tennessee Mouse Genome Consortium
- UTHSC Mid-South Center for Biodefense and Security
For more information, visit: www.uthsc.edu/research
University of Tennessee Health Science Center College of Pharmacy
The new UTHSC College of Pharmacy building on the University of Tennessee Health Science Center campus is complete and includes.
•184,000 gross square feet, spread across several floors.
•Classrooms, seminar rooms, scientific laboratories, computer labs, conference rooms, clinical learning center, technology center, staff offices, and storage areas.
The new building consolidates pharmaceutical lab work on four floors.
The Plough Foundation awarded a grant of $4.5 million to the University of Tennessee Health Science Center (UTHSC) College of Pharmacy. The grant will be used to establish the Plough Center for Sterile Drug Delivery Systems, a more than 5,800-square-foot facility on the sixth floor of the new UT College of Pharmacy Building. The Plough Center serves as an educational hub for teaching and training pharmacists, pharmaceutical scientists, and highly skilled employees for the pharmaceutical and biotechnology industry. The Plough Center also provides an environment for the development of unique drug products to solve specialized problems. Funds from the Plough Foundation grant will cover all project costs for the center including design, construction and equipment, plus data and telecommunications.